Wei Liu

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Weiwei Tao · 1 shared paper, 2026 · strength 0.32
   • Paper Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. DOI 10.1016/j.phymed.2025.157665↗
2. Ming Zhao · 1 shared paper, 2026 · strength 0.32
   • Paper Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. DOI 10.1016/j.phymed.2025.157665↗
3. Si‐Nan Lu · 1 shared paper, 2026 · strength 0.32
   • Paper Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. DOI 10.1016/j.phymed.2025.157665↗
4. Lu Cai · 1 shared paper, 2026 · strength 0.32
   • Paper Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. DOI 10.1016/j.phymed.2025.157665↗
5. Ruizhe He · 2 shared papers, 2021–2022 · strength 0.24
   • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
   • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
6. Jian‐Yu Yang · 2 shared papers, 2021–2022 · strength 0.24
   • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
   • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
7. Xueliang Fu · 2 shared papers, 2021–2022 · strength 0.24
   • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
   • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
8. Yongwei Sun · 2 shared papers, 2021–2022 · strength 0.24
   • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
   • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
9. Minwei Yang · 2 shared papers, 2021–2022 · strength 0.24
   • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
   • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
10. Rong Hua · 2 shared papers, 2021–2022 · strength 0.24
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
    • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
11. Yan‐Miao Huo · 2 shared papers, 2021–2022 · strength 0.24
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
    • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
12. Shu‐Heng Jiang · 2 shared papers, 2021–2022 · strength 0.24
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
    • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
13. Xianming Kong · 1 shared paper, 2022 · strength 0.13
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
14. Jian Yang · 1 shared paper, 2022 · strength 0.13
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
15. Dejun Liu · 1 shared paper, 2022 · strength 0.13
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
16. Jia-Hao Zheng · 1 shared paper, 2022 · strength 0.13
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
17. Hong‐Fei Yao · 1 shared paper, 2022 · strength 0.13
    • Paper IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer. DOI 10.1007/s13402-022-00670-z↗
18. Junfeng Zhang · 1 shared paper, 2021 · strength 0.12
    • Paper SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. DOI 10.1002/1878-0261.12970↗
19. Jiaxin Tan · 1 shared paper, 2016 · strength 0.06
    • Paper Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vit… DOI 10.1007/s00432-016-2206-4↗
20. Yu You · 1 shared paper, 2016 · strength 0.06
    • Paper Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vit… DOI 10.1007/s00432-016-2206-4↗
21. Ping Bie · 1 shared paper, 2016 · strength 0.06
    • Paper Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vit… DOI 10.1007/s00432-016-2206-4↗
22. Haisu Dai · 1 shared paper, 2016 · strength 0.06
    • Paper Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vit… DOI 10.1007/s00432-016-2206-4↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.